--- title: "Charles River Laboratories International Inc. Stock Outperforms Competitors On Strong Trading Day" type: "News" locale: "en" url: "https://longbridge.com/en/news/273753657.md" description: "Charles River Laboratories International Inc. (CRL) shares rose 1.25% to $222.35 on a strong trading day, outperforming competitors like Labcorp Holdings Inc. and Alnylam Pharmaceuticals Inc. The S&P 500 Index increased by 0.50%, while the Dow Jones Industrial Average rose by 0.64%. CRL's stock is currently 2.85% below its 52-week high of $228.88. Trading volume was below the 50-day average, with 440,973 shares traded." datetime: "2026-01-26T22:17:48.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/273753657.md) - [en](https://longbridge.com/en/news/273753657.md) - [zh-HK](https://longbridge.com/zh-HK/news/273753657.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/273753657.md) | [繁體中文](https://longbridge.com/zh-HK/news/273753657.md) # Charles River Laboratories International Inc. Stock Outperforms Competitors On Strong Trading Day This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Charles River Laboratories International Inc. (CRL) advanced 1.25% to $222.35 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.50% to 6,950.23 and the Dow Jones Industrial Average rising 0.64% to 49,412.40. The stock's rise snapped a two-day losing streak. Charles River Laboratories International Inc. closed 2.85% below its 52-week high of $228.88, which the company reached on January 13th. The stock outperformed some of its competitors Monday, as Labcorp Holdings Inc. (LH) rose 0.27% to $267.38, Alnylam Pharmaceuticals Inc. (ALNY) rose 0.94% to $361.35, and Bio-Techne Corp. (TECH) fell 0.78% to $67.63. Trading volume (440,973) remained 342,833 below its 50-day average volume of 783,806. Data source: Dow Jones Market Data, FactSet. Data compiled January 26, 2026. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 01-26-26 1717ET ### Related Stocks - [ProShares Ultra Dow30 (DDM.US)](https://longbridge.com/en/quote/DDM.US.md) - [First Trust NYSE Arca Biotech ETF (FBT.US)](https://longbridge.com/en/quote/FBT.US.md) - [ProShares UltraPro Dow30 (UDOW.US)](https://longbridge.com/en/quote/UDOW.US.md) - [Invesco Nasdaq Biotechnology ETF (IBBQ.US)](https://longbridge.com/en/quote/IBBQ.US.md) - [Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU.US)](https://longbridge.com/en/quote/TBXU.US.md) - [ARK Genomic Revolution ETF (ARKG.US)](https://longbridge.com/en/quote/ARKG.US.md) - [Invesco Dow Jones Industrial Avg Div ETF (DJD.US)](https://longbridge.com/en/quote/DJD.US.md) - [iShares Genomics Immnlgy & Hlthcr ETF (IDNA.US)](https://longbridge.com/en/quote/IDNA.US.md) - [Invesco S&P 500® Low Volatility ETF (SPLV.US)](https://longbridge.com/en/quote/SPLV.US.md) - [Charles River Laboratories International, Inc. (CRL.US)](https://longbridge.com/en/quote/CRL.US.md) - [Dow Jones Industrial Average (.DJI.US)](https://longbridge.com/en/quote/.DJI.US.md) - [iShares Core S&P 500 ETF (IVV.US)](https://longbridge.com/en/quote/IVV.US.md) - [ProShares Ultra Nasdaq Biotechnology (BIB.US)](https://longbridge.com/en/quote/BIB.US.md) - [Invesco S&P 500® Equal Weight ETF (RSP.US)](https://longbridge.com/en/quote/RSP.US.md) - [SPDR® S&P 500® ETF (SPY.US)](https://longbridge.com/en/quote/SPY.US.md) - [iShares US Pharmaceuticals ETF (IHE.US)](https://longbridge.com/en/quote/IHE.US.md) - [Vanguard S&P 500 ETF (VOO.US)](https://longbridge.com/en/quote/VOO.US.md) - [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/en/quote/PBE.US.md) - [VanEck Biotech ETF (BBH.US)](https://longbridge.com/en/quote/BBH.US.md) - [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/en/quote/IBB.US.md) - [ALPS Medical Breakthroughs ETF (SBIO.US)](https://longbridge.com/en/quote/SBIO.US.md) - [iShares Dow Jones US ETF (IYY.US)](https://longbridge.com/en/quote/IYY.US.md) - [S&P 500 (.SPX.US)](https://longbridge.com/en/quote/.SPX.US.md) - [SPDR® Dow Jones Industrial Avrg ETF Tr (DIA.US)](https://longbridge.com/en/quote/DIA.US.md) - [Alnylam Pharmaceuticals, Inc. (ALNY.US)](https://longbridge.com/en/quote/ALNY.US.md) - [Labcorp Holdings Inc. (LH.US)](https://longbridge.com/en/quote/LH.US.md) - [State Street® SPDR® S&P® Biotech ETF (XBI.US)](https://longbridge.com/en/quote/XBI.US.md) - [Dow Jones U.S. Index (.DJUS.US)](https://longbridge.com/en/quote/.DJUS.US.md) ## Related News & Research - [Why Is the SPY ETF Up Today, 4/1/2026?](https://longbridge.com/en/news/281428290.md) - [Should You Really Invest in the Vanguard S&P 500 ETF Right Now? Here's What History Says.](https://longbridge.com/en/news/281360255.md) - [LIVE MARKETS-Dow in correction: Can Fibonacci support spark a reversal?](https://longbridge.com/en/news/281026597.md) - [Here's How Much $100 Invested In ProShares UltraPro S&P 500 5 Years Ago Would Be Worth Today](https://longbridge.com/en/news/281388760.md) - [S&P 500 Earnings Season Preview: Q1 2026](https://longbridge.com/en/news/281555757.md)